Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial

por Fujiwara, Keiichi, Fujiwara, Hiroyuki, Yoshida, Hiroyuki, Satoh, Toyomi, Yonemori, Kan, Nagao, Shoji, Matsumoto, Takashi, Kobayashi, Hiroaki, Bourgeois, Hughes, Harter, Philipp, Mosconi, Anna Maria, Vazquez, Isabel Palacio, Reinthaller, Alexander, Fujita, Tomoko, Rowe, Philip, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle
Publicado 2021